The Ligation Devices Market is expected to witness a CAGR of 6-7% by 2028. The key factors driving the market are the rising ...

2025 Adjusted EPS Guidance: $13.20 to $13.60. Teleflex Inc (NYSE:TFX) reported first quarter revenues of $700.7 million, which was within the guidance range provided during the previous earnings call.

Teleflex (TFX) came out with quarterly earnings of $2.91 per share, beating the Zacks Consensus Estimate of $2.88 per share. This compares to earnings of $3.21 per share a year ago. These figures ...

WAYNE, Pa. (AP) — WAYNE, Pa. (AP) — Teleflex Inc. (TFX) on Thursday reported first-quarter net income of $95 million. On a per-share basis, the Wayne, Pennsylvania-based company said it had ...

Revised EPS guidance incorporates the completed $300 million accelerated share repurchase "Our performance for the first quarter was in line with our expectations" said Liam Kelly, Teleflex's Chairman ...

WAYNE, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced U.S. Food and Drug Administration (FDA ...

WAYNE, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX), will be presenting at the BofA Securities 2025 Health Care Conference at the Encore Hotel in Las ...

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Teleflex Incorporated ...

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Teleflex Incorporated (NYSE: TFX) resulting from ...